APA (7th ed.) Citation

Frederick Berro Rivera, Linnaeus Louisse A. Cruz, John Vincent Magalong, Jade Monica Marie J. Ruyeras, John Paul Aparece, Nathan Ross B. Bantayan, . . . Martha Gulati. (2024). Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials. Elsevier.

Chicago Style (17th ed.) Citation

Frederick Berro Rivera, Linnaeus Louisse A. Cruz, John Vincent Magalong, Jade Monica Marie J. Ruyeras, John Paul Aparece, Nathan Ross B. Bantayan, Kyla Lara-Breitinger, and Martha Gulati. Cardiovascular and Renal Outcomes of Glucagon-like Peptide 1 Receptor Agonists Among Patients with and Without Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Placebo-controlled Trials. Elsevier, 2024.

MLA (9th ed.) Citation

Frederick Berro Rivera, et al. Cardiovascular and Renal Outcomes of Glucagon-like Peptide 1 Receptor Agonists Among Patients with and Without Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Placebo-controlled Trials. Elsevier, 2024.